Best ablation strategy in patients with premature ventricular contractions with multiple morphology: a single-centre

Sanghamitra Mohanty1, John D Burkhardt1, Luigi Di Biase1,2

  • 1Department of Electrophysiology, Texas Cardiac Arrhythmia Institute, St. David's Medical Center, TCAI: 1015 east 32nd street, suite 408, Austin, TX-78705, USA.

Insights

Ablating all premature ventricular complex (PVC) morphologies, not just the predominant one, significantly reduces PVC burden and improves left ventricular ejection fraction (LVEF) in patients with reduced LVEF. This comprehensive approach offers long-term clinical benefits.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • Reduced left ventricular ejection fraction (LVEF) is often associated with high burden of premature ventricular complexes (PVCs).
  • The optimal ablation strategy for patients with multiple PVC morphologies and reduced LVEF remains under investigation.

Purpose of the Study:

  • To compare the clinical benefits of ablating all PVC morphologies versus only the predominant morphology in patients with reduced LVEF.
  • To assess the long-term impact of these ablation strategies on PVC burden and LVEF.

Main Methods:

  • An observational study included 171 patients with reduced LVEF and high PVC burden (>10%/day) undergoing their first ablation.
  • Initial procedures focused on dominant PVCs in most patients, while a subset underwent ablation of all morphologies.
  • Redo procedures targeted all PVC morphologies, with long-term follow-up assessing PVC burden and LVEF.

Main Results:

  • Ablation of all PVC morphologies was associated with significantly lower PVC burden at long-term follow-up compared to dominant morphology ablation.
  • Patients undergoing ablation of all morphologies showed improved LVEF post-procedure.
  • Successful ablation of all PVC morphologies led to a sustained reduction in PVC burden and LVEF improvement.

Conclusions:

  • Targeted ablation of all PVC morphologies is clinically superior to ablating only the dominant morphology in patients with reduced LVEF.
  • This comprehensive ablation strategy offers significant long-term benefits, including reduced PVC burden and improved cardiac function.
Abstract

Related Concept Videos

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
61
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
1.1K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
21
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
13
Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per...
15
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
18